News-Medical.Net Urinary Tract Infection News Feed
Thousands with chronic UTIs are not receiving the treatment they need
Thu, 21 Feb 2019 04:57:00 -0500
Many women may not be receiving the treatment they need because the gold-standard tests for UTIs fail to detect a significant proportion of bacteria.
Combination of common antibiotics can eliminate multi-drug resistant E. coli
Wed, 20 Feb 2019 13:21:13 -0500
A group of scientists in Denmark is trying to get one step ahead in the battle against antibiotic resistance.
In California, doctors accused of sexual misconduct often get second chances
Fri, 14 Dec 2018 07:43:27 -0500
The doctor instructed his patient to stand in front of him. He cupped her crotch and inserted his fingers into her vagina through her clothes, moving his hand repeatedly to her rectal area. Then he squeezed her breasts, according to a formal accusation filed by the Medical Board of California.
Recurrence of urinary tract infection may depend on bacterial strain, study shows
Fri, 14 Dec 2018 05:51:00 -0500
Genetically diverse bacterial strains that cause urinary tract infections differ in their ability to trigger protective immune responses in mice, potentially explaining why these infections frequently recur in many patients, according to a study published December 13 in the open-access journal PLOS Pathogens by Thomas Hannan and Scott Hultgren of Washington University School of Medicine, and colleagues.
Scientists unravel how bacterial persister cells manipulate our immune cells
Fri, 07 Dec 2018 13:21:00 -0500
New research, from scientists at Imperial College London, unravels how so-called bacterial persister cells manipulate our immune cells, potentially opening new avenues to finding ways of clearing these bacterial cells from the body, and stopping recurrence of the bacterial infection.
New diabetes drugs linked to increased risk of lower-limb amputation and ketoacidosis
Wed, 14 Nov 2018 23:52:49 -0500
The use of a new class of drugs in the treatment of type 2 diabetes, so called SGLT2 inhibitors, are linked to a twofold increased risk for lower-limb amputation as well as diabetic ketoacidosis, a serious diabetes complication.
Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint
Thu, 01 Nov 2018 03:46:24 -0500
Genentech, a member of the Roche Group , announced today that the randomized Phase III CLL14 study, which evaluated fixed-duration Venclexta® in combination with Gazyva® in people with previously untreated chronic lymphocytic leukemia and co-existing medical conditions, met its primary endpoint and showed a statistically significant reduction in the risk of disease worsening or death compared to standard-of-care Gazyva plus chlorambucil.
Relapses are common in patients with drug-resistant urinary tract infections
Tue, 30 Oct 2018 14:59:08 -0500
Patients with a certain drug-resistant urinary tract infection were more likely to have a relapse of their infection within a week than those with non-resistant infections and were more likely to be prescribed an incorrect antibiotic according to a study published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
The Lancet Infectious Diseases journal publishes clinical trial results for Shionogi’s cefiderocol
Fri, 26 Oct 2018 00:33:52 -0500
Shionogi & Co., Ltd. announced today that The Lancet Infectious Diseases journal has published clinical results from the pivotal randomized controlled trial evaluating cefiderocol for the treatment of complicated urinary tract infection in patients at risk of multidrug-resistant Gram-negative infections.
Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer
Mon, 22 Oct 2018 04:19:43 -0500
Genentech, a member of the Roche Group, today announced positive results from the Phase III IMpower130 study of Tecentriq (atezolizumab) plus chemotherapy (carboplatin and Abraxane® [albumin-bound paclitaxel; nab-paclitaxel]) for the initial (first-line) treatment of people with previously untreated metastatic non-squamous non-small cell lung cancer.